Similar articles

• A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.

  Fortin A, Caouette R, Wang CS, Vigneault E. Fortin A, et al. Am J Clin Oncol. 2008 Aug;31(4):379-83. doi: 10.1097/COC.0b013e318165c036. Am J Clin Oncol. 2008. PMID: 18845998
• Concomitant low-dose cisplatin and three-dimensional conformal radiotherapy for locally advanced squamous cell carcinoma of the head and neck: Analysis of survival and toxicity.

  Lau H, Brar S, Hao D, MacKinnon J, Yee D, Gluck S. Lau H, et al. Head Neck. 2006 Mar;28(3):189-96. doi: 10.1002/hed.20324. Head Neck. 2006. PMID: 16265658
• Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials.

  Rewari AN, Haffty BG, Wilson LD, Son YH, Joe JK, Ross DA, Papac RJ, Sasaki CT, Fischer JJ. Rewari AN, et al. Cancer J. 2006 Mar-Apr;12(2):123-9. Cancer J. 2006. PMID: 16630403
• Expanding role of the medical oncologist in the management of head and neck cancer.

  Choong N, Vokes E. Choong N, et al. CA Cancer J Clin. 2008 Jan-Feb;58(1):32-53. doi: 10.3322/CA.2007.0004. Epub 2007 Dec 20. CA Cancer J Clin. 2008. PMID: 18096865 Review.
• Understanding the results of meta-analyses in the treatment of head and neck squamous cell cancer.

  Hotte SJ, Wright JR. Hotte SJ, et al. Hematol Oncol Clin North Am. 2008 Dec;22(6):1257-66, x. doi: 10.1016/j.hoc.2008.09.001. Hematol Oncol Clin North Am. 2008. PMID: 19010272 Review.